3 results
To assess the feasibility and efficacy of 90Y-ibritumomab tiuxetan consolidation treatment after R-PECC chemotherapy as second or third line treatment in patients with refractory or relapsed aggressive B-cell NHL, after or not eligible for…
The aim of this study is to investigate whether the new joints for the sc-kevo's can be effectively operated by the patient, and whether a minimal hip extensor strength is needed to operate the joints succesfully. Secondly, the effect of the…
Improving the clinical effect and efficiency of DBS for PD by investigating patient specific patterns of neuronal cell activity in the brain that are associated with symptom-severity. This may improve the clinical effect of DBS, and also result in…